Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skeletal Myoblast Transplant for Ischemic Heart Failure
NCT00102128Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Nov 2002
- Primary completion
- Apr 2007
- Modality
- Stem Cell Therapies
- Countries
- 6
01
Overview
A Phase 2 trial of autologous skeletal myoblasts in Ischemic Heart Failure (IHF), sponsored by Sanofi. Started Nov 2002; status: terminated.
02
Drugs
autologous skeletal myoblasts
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT00102128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102128.